Inventor · disambiguated record
Frank Stowasser
Also filed as: STOWASSER FRANK
16 granted patents·21 pending applications·37 citations·filing 2007–2024
90Inventor score
Top patents by PatentIndex Score
37 records- 0186US2025059181A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0282US11230559B2Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetateHOFFMANN LA ROCHE·Filed 2018·Granted Jan 25, 2022·4 cites·13 claims
- 0381US9949979B2Use of inhibitors of the activity or function of PI3KNOVARTIS AG·Filed 2012·Granted Apr 24, 2018·9 cites·9 claims
- 0481US8436177B2Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrileSTOWASSER FRANK·Filed 2007·Granted May 7, 2013·8 cites·32 claims
- 0576US7989494B2Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamideNOVARTIS AG·Filed 2007·Granted Aug 2, 2011·3 cites·42 claims
- 0676US2022267318A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0775US10786571B2Hydrophilic gel for topical delivery of 5-aminolevulinic acidZIMMER BIOTECH GMBH·Filed 2016·Granted Sep 29, 2020·4 cites·15 claims
- 0874US8653092B2Tetrahydro-pyrido-pyrimidine derivativesCOOKE NIGEL GRAHAM·Filed 2011·Granted Feb 18, 2014·2 cites·21 claims
- 0973US9006270B2Polymorphs of (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amideGALLOU ISABELLE SYLVIE·Filed 2012·Granted Apr 14, 2015·4 cites·15 claims
- 1070US2020392132A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1168US2019218217A1Tetrahydro-Pyrido-Pyrimidine Derivatives as PI3Kdelta inhibitorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1268US2025109149A1Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of makingHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1366US2019040061A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1465US2018265509A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1562US9499536B2Tetrahydro-pyrido-pyrimidine derivativesCOOKE NIGEL GRAHAM·Filed 2014·Granted Nov 22, 2016·0 cites·8 claims
- 1661US12122789B2Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of makingHOFFMANN LA ROCHE·Filed 2021·Granted Oct 22, 2024·0 cites·31 claims
- 1761US8563556B2Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid saltsGIRON DANIELLE·Filed 2009·Granted Oct 22, 2013·3 cites·7 claims
- 1861US2017267678A1Tetrahydro-Pyrido-Pyrimidine DerivativesCOOKE NIGEL GRAHAM·Filed 2017·Application pending·0 cites
- 1959US12012420B2Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetateHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·16 claims
- 2059US12012421B2Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetateHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·13 claims
- 2159US2017022199A1Tetrahydro-Pyrido-Pyrimidine DerivativesCOOKE NIGEL GRAHAM·Filed 2016·Application pending·0 cites
- 2256US2009197936A1Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamideNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2353US8119841B2Crystalline forms of aliskiren hemifumarateSTOWASSER FRANK·Filed 2007·Granted Feb 21, 2012·0 cites·23 claims
- 2452US2009209502A1Compositions of glycopyrronium salt for inhalationHAEBERLIN BARBARA·Filed 2007·Application pending·0 cites
- 2551US2025171428A1Crystalline forms of 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4- yl)methoxy)- n -(tetrahydrapyran-4-yl)pyridazine-3-carboxamideHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2650US8178566B2Crystal form of epothilone B and use in pharmaceutical compositionsKUESTERS ERNST·Filed 2007·Granted May 15, 2012·0 cites·5 claims
- 2748US10314784B2Compositions of glycopyrronium salt for inhalationHAEBERLIN BARBARA·Filed 2015·Granted Jun 11, 2019·0 cites·6 claims
- 2848US2023120311A1Salts and crystalline forms of a taar1 agonistHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2948US2011112308A1Salts of N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamideNOVARTIS AG·Filed 2011·Application pending·0 cites
- 3046US2012065174A1Compositions of glycopyrronium salt for inhalationHAEBERLIN BARBARA·Filed 2011·Application pending·0 cites
- 3146US2010286409A1Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamideNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3245US2020376122A1Hydrophilic gel for topical delivery of 5-aminolevulinic acidZIMMER BIOTECH GMBH·Filed 2020·Application pending·0 cites
- 3345US2013289064A1Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrileSTOWASSER FRANK·Filed 2013·Application pending·0 cites
- 3441US2015224194A1Compositions of Glycopyrronium Salt for InhalationHAEBERLIN BARBARA·Filed 2015·Application pending·0 cites
- 3541US2010130616A1Salt of aliskiren with orotic acidNOVARTIS AG·Filed 2007·Application pending·0 cites
- 3633US10188696B2Pharmaceutical compositionsGONCALVES ELISABETE·Filed 2016·Granted Jan 29, 2019·0 cites·10 claims
- 3729US2014005123A1Pharmaceutical compositionsGONCALVES ELISABETE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →